BMC Cancer (Feb 2006)

Quantitative real-time RT-PCR validation of differential mRNA expression of <it>SPARC</it>, <it>FADD</it>, <it>Fascin</it>, <it>COL7A1</it>, <it>CK4</it>, <it>TGM3</it>, <it>ECM1</it>, <it>PPL </it>and <it>EVPL </it>in esophageal squamous cell carcinoma

  • Wang Yuan,
  • Wang Quan-Hong,
  • Giffen Carol,
  • Wang Chaoyu,
  • Shou Jian-Zhong,
  • Hu Ying,
  • Qian Luxia,
  • Hu Nan,
  • Goldstein Alisa M,
  • Emmert-Buck Michael,
  • Taylor Philip R

DOI
https://doi.org/10.1186/1471-2407-6-33
Journal volume & issue
Vol. 6, no. 1
p. 33

Abstract

Read online

Abstract Background Esophageal squamous cell carcinoma (ESCC) is one of the most malignant tumors and typically presents at an advanced and rapidly fatal stage. To better understand the role of genetics in the etiology and prevention of ESCC and to identify potential susceptibility genes as well as early detection markers, we previously compared tumor and matched normal tissues from ESCC patients from a high-risk area of China using cDNA expression microarrays and identified 41 differentially-expressed genes (13 over-expressed and 28 under-expressed). Methods In the current study, we validated and quantitated differential mRNA expression in a sample of nine of these 41 genes, including four that were over-expressed (SPARC, FADD, Fascin, COL7A1), and five that were under-expressed (CK4, TGM3, ECM1, PPL, EVPL), in 75 new ESCC patients using quantitative Real-time RT-PCR and the 2-ΔΔCT method to examine both tumor and matched normal tissue. In addition, we examined expression patterns for these genes by selected demographic and clinical characteristics. Results Four previously over-expressed (tumor ≥2-fold normal) genes were all increased in the majority of new ESCC patients: SPARC was increased in 71% of patients, Fascin in 70%, FADD in 63%, and COL7A1 in 57%. Five previously under-expressed (tumor ≤0.5-fold normal) genes similarly showed decreased mRNA expression in two-thirds or more of patients: CK4 was decreased in 83% of patients, TGM3 in 77%, ECM1 in 73%, and PPL and EVPL in 67% each. In subset analyses, associations with age (for COL7A1), family history (for PPL and ECM1), and alcohol use (for SPARC and Fascin) were also noted. Conclusion These data indicate that these nine genes have consistent differential mRNA expression, validating results of our previous cDNA array results, and affirming their potential role in the early detection of ESCC.